Susanne Malander

6PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer.

Maj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth

|Sep 25, 2024
Safe to save blood in ovarian cancer surgery - time to change transfusion habits.

Anna Norbeck, Jesper Bengtsson, Susanne Malander

|May 10, 2023
Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer.

Anna Norbeck, Mihaela Asp, Tobias Carlsson

|May 25, 2022
Ovarian tumor frozen section, a multidisciplinary affair.

Mihaela Asp, Ebba Peber, Päivi Kannisto

|Nov 25, 2020
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery.

Maria Bååth, Sofia Westbom-Fremer, Laura Martin de la Fuente

|Oct 31, 2019
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method.

Nicolai Skovbjerg Arildsen, Laura Martin de la Fuente, Anna Måsbäck

Pageof 1